封面
市场调查报告书
商品编码
1543948

全球介入性神经设备市场

Interventional Neurology Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球介入性神经设备市场将达49亿美元

2023年全球介入神经设备市场估计为36亿美元,预计2030年将达到49亿美元,2023-2030年分析期间复合年增长率为4.6%。脑栓塞和动脉瘤弹簧圈栓塞装置是本报告分析的细分市场之一,预计复合年增长率为 4.8%,到分析期结束时将达到 20 亿美元。在分析期间,脑血管成形术和支架系统领域的复合年增长率预计为 3.1%。

美国市场预估价值9.743亿美元,中国预期复合年增长率为4.3%

预计 2023 年美国介入性神经设备市场规模将达 9.743 亿美元。中国作为全球第二大经济体,预计2030年市场规模将达到7.736亿美元,2023年至2030年复合年增长率为4.3%。其他值得注意的区域市场包括日本和加拿大,在分析期间预计复合年增长率分别为 4.5% 和 3.7%。在欧洲,德国的复合年增长率预计为 3.8%。

全球介入神经科设备市场 - 主要趋势和驱动因素总结

什么是介入神经设备?

介入性神经设备是用于微创治疗中风、动脉瘤和动静脉畸形 (AVM) 等神经血管疾病的专用医疗设备。这些设备包括导管、支架、栓塞弹簧圈和血栓移除系统,旨在引导大脑复杂而脆弱的脉管系统。介入性神经病学是现代医学中至关重要的领域,因为它为患者提供了一种比传统开放性手术侵入性更小的替代方案,从而缩短了康復时间,降低了併发症的风险,并改善了治疗结果。随着神经血管疾病的盛行率在全球范围内持续上升,对先进介入神经设备的需求不断增加,使其成为治疗和管理这些危及生命的疾病的重要工具。

科技进步如何形塑介入神经设备市场?

技术进步正在显着塑造介入神经设备市场,特别是透过影像处理、导管设计和材料科学方面的创新。高解析度 3D血管造影术和即时术中成像等诊断成像技术的进步透过提供脑血管系统的详细可视化来提高神经血管手术的准确性和安全性。更灵活、可操纵的导管的开发提高了介入医生在复杂动脉途径中导航的能力,降低了血管损伤的风险并提高了手术成功率。材料科学的创新,包括使用生物相容性和渗透性材料,使支架和栓塞弹簧圈等设备更安全、更有效,从而更有效地治疗复杂的神经血管疾病。这些技术趋势正在推动介入性神经装置在医疗保健环境中的采用,从而为神经血管疾病患者提供更有效、更侵入性的治疗选择。

为什么医疗保健领域对介入神经科设备的需求不断增加?

由于神经血管疾病的盛行率不断增加、人口老化以及微创手术采用率的不断提高,医疗保健领域对介入性神经设备的需求不断增加。中风仍然是全球死亡和残疾的主要原因,因此需要有效的治疗方案,例如血栓切除装置和栓塞弹簧圈。人口老化也增加了对介入神经设备的需求,因为老年人患动脉瘤和动静脉畸形等需要先进介入治疗的疾病的风险更高。患者和医疗保健提供者寻求开放性手术的替代方案,以实现更快的恢復时间、更短的住院时间和更低的併发症发生率。此外,介入神经科医生的专业培训和中风中心的扩张提高了医疗机构执行复杂神经血管手术的能力,并增加了这些设备的采用。随着神经血管疾病负担持续增加,介入神经器械的需求预计将增加。

推动介入性神经设备市场成长的因素有哪些?

介入性神经设备市场的成长受到多种因素的推动,包括技术进步、人口趋势以及对微创治疗的日益关注。主要驱动因素之一是中风和动脉瘤等神经血管疾病的盛行率不断上升,需要先进的介入设备进行有效治疗。世界人口老化也是一个主要的成长要素,因为老年人更容易患上需要介入治疗的神经血管疾病。对微创手术的日益偏好进一步推动了市场的发展。这是因为这些手术比传统的开放性手术具有许多优点,包括更快的恢復和更低的併发症风险。影像处理、导管设计和材料方面的技术进步也透过提高介入神经手术的安全性、有效性和可及性来推动市场成长。此外,对医疗基础设施的投资增加和专业卒中中心的扩张也为介入神经设备的采用创造了新的机会。随着这些因素继续影响医疗保健环境,对神经血管疾病的先进、有效和微创治疗方案的需求预计将推动介入神经设备市场的持续成长。

调查企业范例(共43例)

  • Abbott Laboratories
  • ACANDIS GmbH
  • B. Braun Melsungen AG
  • Bayer AG
  • Biosensors International Group Ltd.
  • Boston Scientific Corporation
  • DePuy Synthes
  • evonos GmbH & Co. KG
  • Medtronic, Inc.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Surtex Instruments
  • Terumo Corporation
  • WL Gore & Associates, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP12822

Global Interventional Neurology Devices Market to Reach US$4.9 Billion by 2030

The global market for Interventional Neurology Devices estimated at US$3.6 Billion in the year 2023, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Cerebral Embolization & Aneurysm Coiling Device, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Cerebral Angioplasty & Stenting Systems segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$974.3 Million While China is Forecast to Grow at 4.3% CAGR

The Interventional Neurology Devices market in the U.S. is estimated at US$974.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$773.6 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Interventional Neurology Devices Market - Key Trends & Drivers Summarized

What Are Interventional Neurology Devices and Why Are They Crucial in Treating Neurovascular Disorders?

Interventional neurology devices are specialized medical instruments used in the minimally invasive treatment of neurovascular disorders, such as strokes, aneurysms, and arteriovenous malformations (AVMs). These devices include catheters, stents, embolization coils, and clot retrieval systems, which are designed to navigate the intricate and delicate vasculature of the brain. Interventional neurology has become a crucial field in modern medicine, as it offers patients less invasive alternatives to traditional open surgeries, leading to faster recovery times, reduced risk of complications, and improved outcomes. As the prevalence of neurovascular disorders continues to rise globally, the demand for advanced interventional neurology devices is increasing, making them essential tools in the treatment and management of these life-threatening conditions.

How Are Technological Advancements Shaping the Interventional Neurology Devices Market?

Technological advancements are significantly shaping the interventional neurology devices market, particularly through innovations in imaging, catheter design, and materials science. Advances in imaging technologies, such as high-resolution 3D angiography and real-time intraoperative imaging, are enhancing the precision and safety of neurovascular procedures by providing detailed visualization of the brain’s vasculature. The development of more flexible and steerable catheters is improving the ability of interventionalists to navigate complex arterial pathways, reducing the risk of vessel injury and improving procedural success rates. Innovations in materials science, including the use of biocompatible and radiopaque materials, are enhancing the safety and efficacy of devices such as stents and embolization coils, making them more effective in treating complex neurovascular conditions. These technological trends are driving the adoption of interventional neurology devices across healthcare settings, as they enable more effective and less invasive treatment options for patients with neurovascular disorders.

Why Is There an Increasing Demand for Interventional Neurology Devices in Healthcare?

The demand for interventional neurology devices is increasing in healthcare due to the growing prevalence of neurovascular disorders, the aging population, and the rising adoption of minimally invasive procedures. Stroke remains a leading cause of death and disability worldwide, driving the need for effective treatment options such as thrombectomy devices and embolization coils. The aging population is also contributing to the demand for interventional neurology devices, as older adults are at higher risk for conditions such as aneurysms and AVMs that require advanced interventional treatment. The trend towards minimally invasive procedures is further fueling demand, as patients and healthcare providers seek alternatives to open surgeries that offer faster recovery times, reduced hospital stays, and lower complication rates. Additionally, the increasing availability of specialized training for interventional neurologists and the expansion of stroke centers are enhancing the adoption of these devices, as more healthcare facilities are equipped to perform complex neurovascular procedures. As the burden of neurovascular diseases continues to grow, the demand for interventional neurology devices is expected to increase.

What Factors Are Driving the Growth in the Interventional Neurology Devices Market?

The growth in the interventional neurology devices market is driven by several factors related to technological advancements, demographic trends, and the increasing focus on minimally invasive treatments. One of the primary drivers is the rising prevalence of neurovascular disorders, such as strokes and aneurysms, which require advanced interventional devices for effective treatment. The aging global population is also a significant growth factor, as older adults are more susceptible to neurovascular conditions that necessitate interventional care. The growing preference for minimally invasive procedures is further propelling the market, as these techniques offer numerous benefits over traditional open surgeries, including faster recovery and reduced risk of complications. Technological advancements in imaging, catheter design, and materials are also driving market growth by improving the safety, efficacy, and accessibility of interventional neurology procedures. Additionally, the increasing investment in healthcare infrastructure and the expansion of specialized stroke centers are creating new opportunities for the adoption of interventional neurology devices. As these factors continue to influence the healthcare landscape, the interventional neurology devices market is expected to experience sustained growth, driven by the need for advanced, effective, and minimally invasive treatment options for neurovascular disorders.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • ACANDIS GmbH
  • B. Braun Melsungen AG
  • Bayer AG
  • Biosensors International Group Ltd.
  • Boston Scientific Corporation
  • DePuy Synthes
  • evonos GmbH & Co. KG
  • Medtronic, Inc.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Surtex Instruments
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Interventional Neurology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Neurological Disorders Spurs Demand for Interventional Neurology Devices
    • Advancements in Imaging Technologies Propel Innovation in Neurovascular Interventions
    • Expansion of Minimally Invasive Surgical Techniques Drives Adoption of Neurology Devices
    • Shift Towards Catheter-Based Interventions Expands Market Opportunities
    • Role of Artificial Intelligence in Improving the Precision of Neurological Interventions
    • Increasing Use of Embolic Protection Devices Strengthens the Business Case for Adoption
    • Advancements in Thrombectomy Devices Propel Growth in Acute Stroke Management
    • Growing Importance of Early Diagnosis and Intervention in Neurovascular Conditions
    • Emerging Markets Present New Opportunities for Interventional Neurology Device Providers
    • Push for Cost-Effective Solutions in Stroke Treatment and Neurovascular Care
    • Role of Telemedicine and Remote Monitoring in Supporting Interventional Neurology
    • Increasing Focus on Patient-Centric Care and Customized Treatment Solutions
    • Growing Prevalence of Obesity Spurs Demand for Intragastric Balloons
    • Advancements in Minimally Invasive Weight Loss Solutions Propel Market Growth
    • Shift Towards Non-Surgical Bariatric Procedures Expands Market Opportunities
    • Rising Awareness of Obesity-Related Health Risks Drives Adoption of Intragastric Balloons
    • Increasing Focus on Lifestyle Modification and Weight Management Programs
    • Role of Multidisciplinary Approaches in Enhancing the Efficacy of Intragastric Balloons
    • Advancements in Balloon Design and Material Innovation Enhance Patient Safety and Comfort
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Interventional Neurology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Interventional Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cerebral Embolization & Aneurysm Coiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cerebral Embolization & Aneurysm Coiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cerebral Embolization & Aneurysm Coiling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cerebral Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cerebral Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Cerebral Angioplasty & Stenting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neurothrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neurothrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Neurothrombectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Support by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Support by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Support by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cerebral Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cerebral Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Cerebral Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Strokes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cerebral Artery Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cerebral Artery Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Cerebral Artery Stenosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • JAPAN
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • CHINA
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • EUROPE
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Interventional Neurology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Interventional Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • FRANCE
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • GERMANY
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030

IV. COMPETITION